No improvement in long-term overal survival after the introduction of chemo(immuno)therapy for chronic lymphocytic leukemia patients belonging to stereotyped subsets 2.

• Authors: BALIAKAS P.; MATTSSON M.; HADZIDIMITRIOU A.; MINGA E.; AGATHANGELIDIS A.; SUTTON LA.; SCARFO L.; DAVIS Z.; YAN XJ.; PLEVOVÁ Karla; SANDBERG Y.; JUHL VOJDEMAN F.; TZENOU T.; CHU CC.; VERONEZE S.; MANSOURI L.; SMEDBY KE.; GIUDICELLI V.; NGUYEN KHAC F.; PANAGIOTIDIS P.; JULIUSSON G.; ANAGNOSTOPOULOS A.; LEFRANC MP.; TRENTIN L.; CATHERWOOD M.; MONTILLO M.; NIEMANN CU.; LANGERAK AW.; POSPÍŠILOVÁ Šárka; STAVROYIANNI N.; CHIORAZZI N.; OSCIER D.; JELINEK D.; SHANAFELT T.; DARZENTAS Nikos; BELESSI C.; DAVI F.; GHIA P.; ROSENQUIST R.; STAMATOPOULOS K.
• Year of publication: 2016
• Type: Conference abstract
• MU Faculty or unit: Central European Institute of Technology